{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:41:39Z","timestamp":1778096499454,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Funds for Statutory Activity of Medical University of Lublin, Poland"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.brainresbull.2019.05.021","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:16:11Z","timestamp":1559301371000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice"],"prefix":"10.1016","volume":"150","author":[{"given":"Ewa","family":"Poleszak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Wo\u015bko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"S\u0142awi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Szopa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Szponar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2019.05.021_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2007.05.006","article-title":"Neuropharmacological effects of oleamide in male and female mice","volume":"182","author":"Akanmu","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euroneuro.2010.06.007","article-title":"Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype","volume":"21","author":"Aso","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1471-4159.2007.05149.x","article-title":"BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice","volume":"105","author":"Aso","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0020","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0025","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1073\/pnas.95.8.4102","article-title":"Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide","volume":"95","author":"Boger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0035","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2012.36","article-title":"Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice","volume":"37","author":"Dubreucq","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.phrs.2009.12.013","article-title":"A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy","volume":"61","author":"Eisenstein","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","article-title":"Inhibition of monoamine oxidase activity by cannabinoids Naunyn Schmiedebergs","volume":"381","author":"Fisar","year":"2010","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0050","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuroscience.2007.02.021","article-title":"Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice","volume":"146","author":"Haring","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0055","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"Hill","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0070","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1038\/sj.npp.1301092","article-title":"Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"31","author":"Hill","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9378(99)70583-1","article-title":"Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta","volume":"181","author":"Kenney","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cbi.2018.07.018","article-title":"Therapeutic applications of cannabinoids","volume":"293","author":"Maurya","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00213-017-4548-2","article-title":"Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor","volume":"234","author":"McLaughlin","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.09.055","article-title":"Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"624","author":"McLaughlin","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2017.11.029","article-title":"Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects","volume":"192","author":"Mendiguren","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.01.002","article-title":"Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats","volume":"534","author":"Mendiguren","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-006-0689-4","article-title":"Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality","volume":"192","author":"Naidu","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbr.2016.09.059","article-title":"Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection","volume":"317","author":"Nasehi","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1440-1681.12518","article-title":"Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice","volume":"43","author":"Ostadhadi","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-540-88955-7_14","article-title":"Role of endocannabinoid signaling in anxiety and depression","volume":"1","author":"Patel","year":"2009","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11011-016-9810-5","article-title":"Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice","volume":"31","author":"Poleszak","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharep.2015.06.138","article-title":"Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice","volume":"68","author":"Poleszak","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0165","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0170","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1213\/ANE.0b013e3182707859","article-title":"CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system","volume":"116","author":"Romero","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00210-005-0026-1","article-title":"De MR. Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex","volume":"372","author":"Sagredo","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2010.09.039","article-title":"Systemic cannabinoids produce CB(1)-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors","volume":"649","author":"Seyrek","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2008.05.020","article-title":"Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests","volume":"589","author":"Takahashi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2011.04.031","article-title":"Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice","volume":"223","author":"Umathe","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0200","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.biopsych.2004.11.033","article-title":"Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims","volume":"57","author":"Vinod","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036743","article-title":"Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats","volume":"7","author":"Vinod","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jphp.12880","article-title":"CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests","volume":"70","author":"Wosko","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.021_bib0215","first-page":"95","article-title":"[The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction]","volume":"33","author":"Yoshida","year":"2013","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923019302989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923019302989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:37:05Z","timestamp":1759783025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923019302989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":43,"alternative-id":["S0361923019302989"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2019.05.021","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2019.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}